Osaic Holdings’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-300
| Closed | -$19.1K | – | 7217 |
|
2024
Q3 | $19.1K | Hold |
300
| – | – | ﹤0.01% | 5370 |
|
2024
Q2 | $17.8K | Buy |
+300
| New | +$17.8K | ﹤0.01% | 5373 |
|
2022
Q2 | – | Sell |
-200
| Closed | -$12K | – | 7197 |
|
2022
Q1 | $12K | Hold |
200
| – | – | ﹤0.01% | 5979 |
|
2021
Q4 | $16K | Sell |
200
-65
| -25% | -$5.2K | ﹤0.01% | 5904 |
|
2021
Q3 | $25K | Buy |
265
+65
| +33% | +$6.13K | ﹤0.01% | 5599 |
|
2021
Q2 | $20K | Hold |
200
| – | – | ﹤0.01% | 5636 |
|
2021
Q1 | $17K | Hold |
200
| – | – | ﹤0.01% | 5553 |
|
2020
Q4 | $17K | Hold |
200
| – | – | ﹤0.01% | 5199 |
|
2020
Q3 | $14K | Hold |
200
| – | – | ﹤0.01% | 5077 |
|
2020
Q2 | $15K | Sell |
200
-100
| -33% | -$7.5K | ﹤0.01% | 4919 |
|
2020
Q1 | $14K | Buy |
+300
| New | +$14K | ﹤0.01% | 4780 |
|